Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Once-Daily Lopinavir/Ritonavir

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0b013e3181d3cad3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Pharmacokinetic Interactions Between the HCV Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, or Darunavir in Healthy Participants

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Buprenorphine–naloxone

CMAJ
Medicine
2018English

Plasma and Intracellular Pharmacokinetics of Darunavir/Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected Individuals

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2011English

Lopinavir/Ritonavir Population Pharmacokinetics in Neonates and Infants

British Journal of Clinical Pharmacology
Pharmacology
2011English

Abuse Liability of Intravenous Buprenorphine/Naloxone and Buprenorphine Alone in Buprenorphine-Maintained Intravenous Heroin Abusers

Addiction
MedicinePsychiatryMental Health
2010English

Comparisons Between Twice-Daily and Once-Daily Training Sessions in Male Weight Lifters

International Journal of Sports Physiology and Performance
Sports MedicinePhysical TherapySports ScienceOrthopedicsSports TherapyRehabilitation
2007English

Tularemia and Once-Daily Gentamicin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Pharmacokinetic Study of Once Daily 800mg Nabumetone in the Middle-Aged and Elderly Patients With RA.

Ensho
1988English

Pharmacokinetic Study of Once-Daily Versus Twice-Daily Abacavir and Lamivudine in HIV Type-1-Infected Children Aged 3-<36 Months

Antiviral Therapy
Infectious DiseasesPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy